Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
save 25 %
* Required Fields
Pay by invoice
This research service focuses on insulin and non-insulin therapeutics for the treatment of type 1 and 2 diabetes in Latin America. The insulin and non-insulin markets will experience major changes within the next three years, due to the discovery of new drugs. Focus is currently placed on the development of molecules that can help with patients adherence to treatment by offering one weekly drug dose for managing the chronic disease. This deliverable includes information regarding market background, dynamics, challenges, trends, and access. The base year is 2013. Also, provided are a detailed analysis of products on the market and in development within Latin America, as well as clinical trial details and projected drugs launch timelines.
The Most Lucrative Market for CROs in the Asia Pacific in 2015
Top Technologies in Health and Wellness--2013 (Technical Insights)
Frost & Sullivan Awards for Impact of Biomarkers (Technical Insights)
Frost & Sullivan Awards for Innovations in Allergy Diagnostics and Treatment--Technical Insights
Vital Signs - Healthcare News - The Analysts Perspective - February Issue
Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity
Vital Signs - The Healthcare News - March Issue
Vital Signs - The Healthcare News - April Issue
Vital Signs - Healthcare News - The Analysts Perspective June Issue
Vital Signs - Pointing Towards Point-of-Care Testing - The Next Big Shift
diet food market
blood glucose monitoring market
consumer electronics market
digital signage market
augmented reality market
medical supplies market
wearable technology market
smart grid market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.